Updates from The Motley Fool

Latest updates on Cepheid from Fool.com.

Stock Performance

CPHD vs. S&P 500 | 2 Year Performance
CPHD 1-Day Stock Chart
CPHD 5-Day Stock Chart
CPHD 1-Month Stock Chart
CPHD 3-Month Stock Chart
CPHD 6-Month Stock Chart
CPHD 1-Year Stock Chart
CPHD 2-Year Stock Chart
CPHD 5-Year Stock Chart
View Interactive CPHD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cepheid.
Current Price: $28.25
Prev Close: $27.48
Open: $27.51
Bid: $27.51
Ask: $29.70
Day's Range: $27.42 - $28.25
52wk Range: $25.09 - $63.69
Volume: 401,080
Avg Vol 767,741
Market Cap: $2.04B
P/E (ttm): -35.69
EPS (ttm): -$0.77
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cepheid.
CAPS Rating 3 out of 5
240 Outperform
25 Underperform
CAPS All Stars
37 Outperform
8 Underperform

How do you think Cepheid will perform against the market?

You pick for Cepheid is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John L. Bishop, CEO

79% Approve

Based on 30 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cepheid.

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

  • Exchange: NASDAQ
  • Sector: Technology
  • Industry: Electronics